Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Claus Vogelmeier and Andreas Burchert.
Claus Vogelmeier
Connection Strength
0.282
Andreas Burchert
  1. Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia. 2020 08; 34(8):2276-2278.
    View in: PubMed
    Score: 0.222
  2. The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia. 2021 10; 35(10):2917-2923.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.